Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2690089rdf:typepubmed:Citationlld:pubmed
pubmed-article:2690089lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:2690089lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:2690089lifeskim:mentionsumls-concept:C1280477lld:lifeskim
pubmed-article:2690089lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:2690089lifeskim:mentionsumls-concept:C0016884lld:lifeskim
pubmed-article:2690089pubmed:dateCreated1990-1-31lld:pubmed
pubmed-article:2690089pubmed:abstractTextThe following is a review of the present progress and future development in the experimental therapy of Alzheimer disease (AD). Four different approaches are considered, first a molecular genetic one, second neuropeptide delivery, third trophic factors administration and fourth a cholinergic approach. Advantages and disadvantages of presently applied therapeutical experiments are analyzed and discussed together with the author's own experience and results.lld:pubmed
pubmed-article:2690089pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2690089pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2690089pubmed:languageenglld:pubmed
pubmed-article:2690089pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2690089pubmed:citationSubsetIMlld:pubmed
pubmed-article:2690089pubmed:statusMEDLINElld:pubmed
pubmed-article:2690089pubmed:issn0361-7742lld:pubmed
pubmed-article:2690089pubmed:authorpubmed-author:GiacobiniEElld:pubmed
pubmed-article:2690089pubmed:authorpubmed-author:BeckerRRlld:pubmed
pubmed-article:2690089pubmed:issnTypePrintlld:pubmed
pubmed-article:2690089pubmed:volume317lld:pubmed
pubmed-article:2690089pubmed:ownerNLMlld:pubmed
pubmed-article:2690089pubmed:authorsCompleteYlld:pubmed
pubmed-article:2690089pubmed:pagination1121-54lld:pubmed
pubmed-article:2690089pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2690089pubmed:meshHeadingpubmed-meshheading:2690089-...lld:pubmed
pubmed-article:2690089pubmed:meshHeadingpubmed-meshheading:2690089-...lld:pubmed
pubmed-article:2690089pubmed:meshHeadingpubmed-meshheading:2690089-...lld:pubmed
pubmed-article:2690089pubmed:year1989lld:pubmed
pubmed-article:2690089pubmed:articleTitlePresent progress and future development in the therapy for Alzheimer's disease.lld:pubmed
pubmed-article:2690089pubmed:affiliationDepartment of Pharmacology, Southern Illinois University School of Medicine, Springfield 62794-9230.lld:pubmed
pubmed-article:2690089pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2690089pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2690089pubmed:publicationTypeReviewlld:pubmed
pubmed-article:2690089pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed